Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
RFT-5-dgA in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Taxoprexin Treatment for Advanced Skin Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Taxoprexin® Treatment for Advanced Eye Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE4
A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Multiepitope Peptide Vaccination in Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Allovectin-7® for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2